|
|
Other links at Articles > Rheumatology |
| 2. |
Adalimumab and Etanercept Edge Infliximab in RA Therapy
|
|
|
Among tumor necrosis factor alpha blockers, adalimumab and etanercept appear to be more effective and less expensive than infliximab for treatment of patients with rheumatoid arthritis (RA), Dutch researchers report in the September issue of Annals of the Rheumatic Diseases. Reuters Health Information
|
| 4. |
Hyperuricemia, Gout, and the Metabolic Syndrome
|
|
|
Clinicians should be aware of the presence of metabolic syndrome in patients with hyperuricemia or gout in order to reduce the risk for cardiovascular disease.
Current Opinion in Rheumatology
|
| 5. |
Earlier Treatment Tied to More RA Remission
|
|
|
Independently of the class of agent used, rheumatoid arthritis (RA) treated earlier has a greater likelihood of remission, researchers report in a February 2 online paper in Arthritis Care & Research. Reuters Health Information
|
|
|
